New Safety Data Suggests SPRAVATO®▼ (Esketamine Nasal

Beerse, Belgium, Oct. 08, 2023 (GLOBE NEWSWIRE) -- The new safety data is from the ESCAPE-TRD Phase 3b study1Additional findings from this study showed...

Related Keywords

Spain ,Belgium ,United Kingdom ,Barcelona ,Comunidad Autonoma De Cataluna ,Beerse ,Region Flamande ,Clin Psychopharmacol ,Clin Neurosci ,Eduard Vieta ,Johnson ,European Medicines Agency ,Drug Administration ,Patient Health Questionnaire ,Exchange Commission ,None Of The Janssen Pharmaceutical Companies ,Psychology Service Of The Hospital Cl ,European College Of Neuropsychopharmacology Congress ,Janssen Cilag Ltd ,World Health Organization ,Janssen Cilag International ,Janssen Pharmaceutical Companies Of Johnson ,Janssen Pharmaceutical Companies ,European College ,Neuropsychopharmacology Congress ,Professor Eduard Vieta ,Psychology Service ,Report Superior Efficacy ,Annual Report ,Note Regarding Forward Looking ,Quarterly Reports ,Patient Health ,Health Organization ,Dialogues Clin Neurosci ,Medicines Agency ,Indirect Cost Burden ,Employment Status ,Treatment Resistant Depression ,Matched Cohort Study Using ,Exp Clin ,Kingdom Electronic Medicines ,Janssen Emea ,